Page last updated: 2024-11-01

ondansetron and Esophageal and Gastric Varices

ondansetron has been researched along with Esophageal and Gastric Varices in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Esophageal and Gastric Varices: Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation (PORTAL SYSTEM) to the systemic venous circulation. Often they are observed in individuals with portal hypertension (HYPERTENSION, PORTAL).

Research Excerpts

ExcerptRelevanceReference
" We treated the pain of acute arthritis with the specific 5-hydroxytryptamine subtype 3 receptor antagonist ondansetron."7.69Treatment of acute gouty arthritis with the 5-hydroxytryptamine antagonist ondansetron. ( Ramadori, G; Schwörer, H, 1994)
" We treated the pain of acute arthritis with the specific 5-hydroxytryptamine subtype 3 receptor antagonist ondansetron."3.69Treatment of acute gouty arthritis with the 5-hydroxytryptamine antagonist ondansetron. ( Ramadori, G; Schwörer, H, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schwörer, H1
Ramadori, G1

Other Studies

1 other study available for ondansetron and Esophageal and Gastric Varices

ArticleYear
Treatment of acute gouty arthritis with the 5-hydroxytryptamine antagonist ondansetron.
    The Clinical investigator, 1994, Volume: 72, Issue:10

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Colchicine; Contraindications; Eso

1994